Breast Cancer Now calls for immediate action on drugs system reforms

The independent review on access to medicines was conducted by Dr Brian Montgomery. In its response to the review’s recommendations the Scottish...

14 December 2016

Breast Cancer Now responds to NICE decision to approve breast cancer drug eribulin

In its draft updated guidance published today, NICE has said eribulin (also called Halaven and made by Eisai) should be an option for people with...

3 November 2016

Breast Cancer Now and EDF Energy partner for three years

Breast Cancer Now was chosen as EDF Energy’s next charity partner in an employee vote, with thousands of employees across the company taking part....

17 October 2016

Two thirds of Hospital Trusts failing to count patients with incurable breast cancer

Missing “piece of the puzzle” blocking vital improvements to poor patient care Two thirds (66%) of Hospital Trusts in England do not...

22 September 2016

Breast Cancer Now responds to new findings on post-chemotherapy deaths using world-first cancer data

The first major report using world-first systemic anticancer treatment (SACT) data has been published today by Lancet Oncology. It shows that age,...

30 August 2016

Balance campaign raises awareness of link between alcohol and breast cancer

The campaign by Balance, the North East Alcohol Office, aims to raise awareness that even relatively low levels of drinking alcohol can increase the...

4 August 2016

Stress and adverse life events unlikely to cause breast cancer, major study finds

Women with breast cancer often consider stress as a likely cause of their disease, but in the largest study to date of the potential link between...

15 July 2016

New report warns of shocking diagnosis failings for people with incurable breast cancer

Breast Cancer Care’s new report on diagnosis for people with incurable, secondary breast cancer exposes shocking failings – patients...

15 July 2016

New test could predict breast cancer spread more accurately than NHS test

A new test could predict the risk of a woman’s breast cancer spreading within 10 years of diagnosis more accurately than the current NICE-approved...

11 July 2016